The affinity of 6 for the cholera toxin B subunit (CTB)
was determined with a direct fluorescence binding assay.4
CTB contains one tryptophan residue (Trp88), the fluores-
cence of which is affected by the binding of carbohydrate
ligands. Upon addition of 6, the decrease of the CTB
fluorescence was practically complete at saturation. This
phenomenon was also observed for 14 and is in contrast to
lactose, which induces only a minor fluorescence quenching.
For 6 the fluorescence at 350 nm fitted well to a simple one-
binding-site model and the Kd value obtained was 23 µM.
This indicates that 6 binds 1 order of magnitude better than
1 and 780-fold better than lactose.4 In comparison to other
monovalent CT ligands 6 performs remarkably well. Excep-
tional remains the close GM1 mimic of Bernardi et al.10 with
a Kd value similar to GM1 itself (50 nM11), but their
simplified analogue has a Kd of 190 µM.12 For the closely
related heat-labile enterotoxin of E. coli, Hol et al. have found
a lead compound from screening a small library, m-nitro-
phenyl-R-D-galactopyranoside, that has a Kd value determined
by ITC of 175 µM, while their best designed derivative binds
with a Kd of 12 µM.13
In summary, the synthesis and characterization of a lactose-
2-aminothiazoline conjugate 6 was described. This is a stable
compound with no tendency to convert to the corresponding
2-aminothiazole under ambient conditions. The class of
2-aminothiazolines is of interest for a variety of biological
activities,14 and the synthetic method described here will be
further explored in this context. Compound 6 proved to be
a high-affinity monovalent CTB ligand of relatively simple
structure and may contribute to the development of an
effective cholera prophylactic. Computational studies to
decipher the origin of its affinity along with work toward
further affinity enhancement for effective competition with
GM1 through multivalency are currently in progress.
Scheme 1a
a (a) HCtCCH2NHBoc, Pd0, CuI, NEt3, CH3CN, 14 h (62%);
(b) TFA, CH2Cl2 (quant); (c) Lac(OAc)7NCS, CH2Cl2, iPr2NEt,
14 h; (d) AcOH, CH2Cl2 (84% for 2 steps); (e) dioxane/MeOH/4
N NaOH, 15:4:2, (45%).
13C NMR spectrum of this compound showed neither a peak
at 184 ppm characteristic for the carbon of a thiourea moiety
nor the expected triple bond signals. The observed spectral
features were consistent with structure 5 (or its tautomer with
the other nitrogen protonated). The structure assignment is
partly based on the reported7,8 reactions of propargylamines
with isothiocyanates and the related reactions of propargylic
isothiocyanates with amines and was confirmed by several
2D-NMR techniques (see Supporting Information for detailed
structural characterization).
The carbohydrate moiety of 5 was deprotected with base
to yield 6. This compound is insoluble in water, but the
compound obtained after treatment with dilute HCl or formic
acid and lyophylization had good water solubility. Presum-
ably both nitrogens were protonated at this stage, since it is
expected that the pKa should exceed 6.9 A similar NMR
analysis as was used for 5 confirmed the structure of 6. A
stability test for 6 of 1 week in aqueous solution showed
the compound to be stable.
Acknowledgment. The Royal Netherlands Academy of
Arts and Sciences (KNAW) is gratefully acknowledged for
support.
Supporting Information Available: Experimental pro-
cedures for the synthesis of 5 and 6 and their structure
assignment including HMBC, HSQC, ROESY, and MS
spectra. This material is available free of charge via the
OL025909W
(5) Sonogashira, K.; Tohda, Y.; Hagihara, N. Tetrahedron Lett. 1975,
50, 4470.
(6) On TLC two spots with Rf values of 0.36 and 0.27 were observed
(CH2Cl2/MeOH, 95:5 v/v) in a 10:1 ratio. The major product was identified
as 2 by NMR spectra of the mixture.
(10) Bernardi, A.; Checchia, A.; Brocca, P.; Sonnino, S.; Zucotto, F. J.
Am. Chem. Soc. 1999, 121, 2032.
(11) Mertz, J. A.; McCann, J. A.; Picking, W. D. Biochem. Biophys.
Res. Commun. 1996, 226, 140.
(7) Eloy, F.; Deryckere, A. Chim. Ther. 1973, 8, 437.
(8) Ferrand, G.; Maffrand, J. P.; Eloy, F.; Ferrand, J. C. Eur. J. Med.
Chem. 1975, 10, 549.
(9) Hirashima, A.; Tomita, J.; Pan, C.; Taniguchi, E.; Eto, M. Bioorg.
Med. Chem. Lett. 1997, 5, 22121.
(12) Bernardi, A.; Carrettoni, L.; Grosso Ciponte A.; Monti, D.; Sonnino,
S. Bioorg. Med. Chem. Lett. 2000, 10, 2197.
(13) Pickens, J. C.; Merritt, E. A.; Ahn, M.; Verlinde, C. L. M. J.; Hol,
W. G. J.; Fan, E. Chem. Biol. 2002, 9, 215.
(14) Kim, T. H.; Cha, M.-H. Tetrahedron Lett. 1999, 40, 3125.
1808
Org. Lett., Vol. 4, No. 10, 2002